Candel Therapeutics (NASDAQ: CADL ) is a biotech focused on the development of viral therapies meant to treat solid tumors, hoping to find itself succeeding where a long line of others have failed in harnessing theI have my PhD in biochemistry and have worked for years analyzing clinical trials and biotech companies. It is my passion to educate everyone possible on the science behind the businesses that we invest in, and it's my mission to help you do your due diligence and not get burned by the pitfalls of ...